NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

NEJM Interviews
14/09/2024 3 min

Listen "NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma"

Descargar episodio Ver en sitio original

Episode Synopsis


Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

More episodes of the podcast NEJM Interviews

NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States. 07/01/2026
NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services. 31/12/2025
NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend. 17/12/2025
NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. 10/12/2025
NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy. 03/12/2025
NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications. 26/11/2025
NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine. 19/11/2025
NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders. 12/11/2025
NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization. 05/11/2025
NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease. 22/10/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA